ASRT
Assertio Holdings, Inc.Company Information
- Company Name
- Assertio Holdings, Inc.
- CIK
- CIK0001808665
- Category
- Accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ASRT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ASRT
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-11-18
- Last sale
- 2025-11-10
- Shares purchased (TTM)
- 86,706.46
- Shares sold (TTM)
- 8,959
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 2,491,437
- Shares outstanding
- 6,434,000
- Ownership
- 38.72%
Earnings Market Reaction
- Filing date
- 2026-05-08
- Price on filing date
- —
- 1-month reaction
- 4.18%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 34 | 10 | 39 | 47 | 35 | 51 | 38 | 45 | 81 | 73 | 77 | 70 | ||||||
| Short Term Investments | 38 | 53 | 55 | 51 | 52 | 49 | 51 | 44 | - | 0 | - | - | ||||||
| Accounts Receivable Net Current | 62 | 120 | 141 | 61 | 66 | 54 | 45 | 40 | 43 | 48 | 62 | 42 | ||||||
| Inventory Net | 23 | 24 | 25 | 33 | 39 | 38 | 40 | 39 | 39 | 38 | 43 | 19 | ||||||
| Prepaid Expense And Other Assets Current | 11 | 9 | 4 | 18 | 21 | 10 | 8 | 10 | 11 | 12 | 3 | 3 | ||||||
| Assets Current | 167 | 217 | 264 | 210 | 214 | 203 | 181 | 178 | 172 | 171 | 185 | 134 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Deferred Income Tax Assets Net | - | - | - | - | - | - | - | - | - | 0 | 0 | 82 | ||||||
| Intangible Assets Net Excluding Goodwill | 43 | 49 | 55 | 62 | 71 | 80 | 92 | 99 | 106 | 111 | 170 | 185 | ||||||
| Goodwill | - | - | - | - | - | - | - | - | - | - | 20 | - | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 4 | ||||||
| Assets | 211 | 267 | 320 | 274 | 286 | 285 | 276 | 279 | 282 | 286 | 380 | 405 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 6 | 9 | 15 | 11 | 9 | 15 | 13 | 15 | 16 | 13 | 19 | 11 | ||||||
| Customer Refund Liability Current | 62 | 99 | 131 | 86 | 82 | 76 | 60 | 58 | 58 | 58 | 59 | 43 | ||||||
| Accrued Liabilities Current | 18 | 14 | 16 | 31 | 33 | 19 | 13 | 15 | 15 | 18 | 22 | 10 | ||||||
| Business Combination Contingent Consideration Liability Current | - | 0 | 0 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 13 | 15 | ||||||
| Long Term Debt Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Other Liabilities Current | 5 | 5 | 5 | 4 | 4 | 4 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Liabilities Current | 92 | 128 | 167 | 133 | 129 | 115 | 90 | 92 | 92 | 93 | 114 | 79 | ||||||
| Long Term Debt Noncurrent | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 38 | ||||||
| Other Liabilities Noncurrent | 5 | 6 | 8 | 9 | 10 | 10 | 17 | 16 | 16 | 16 | 18 | 6 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 16 | 28 | ||||||
| Liabilities | 136 | 173 | 214 | 180 | 178 | 164 | 145 | 147 | 147 | 148 | 187 | 151 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 798 | 797 | 797 | 796 | 795 | 794 | 793 | 792 | 791 | 790 | 787 | 569 | ||||||
| Retained Earnings Accumulated Deficit | -722 | -703 | -692 | -703 | -687 | -673 | -663 | -660 | -656 | -652 | -594 | -315 | ||||||
| Stockholders Equity | 76 | 94 | 106 | 93 | 109 | 121 | 131 | 132 | 134 | 138 | 193 | 254 | ||||||
| Liabilities And Stockholders Equity | 211 | 267 | 320 | 274 | 286 | 285 | 276 | 279 | 282 | 286 | 380 | 405 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 4 | ||||||
| Shares Outstanding | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 4 | ||||||
| Stockholders Equity Note Stock Split Conversion Ratio1 | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAssertio Holdings, Inc. (ASRT) — SEC Financial Statements & Analysis
Assertio Holdings, Inc. (ASRT) is a pharmaceutical preparations company, incorporated in DE. Assertio Holdings, Inc. trades on Nasdaq as: ASRT. Assertio Holdings, Inc. (ASRT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-08. Based on that filing, On profitability, Assertio Holdings, Inc. posts a gross margin of 70.33%, an operating margin of -26.21%, a net margin of -34.94%, a Return on Equity (ROE) of -38.76%, a Return on Assets (ROA) of -14.34%, and a Return on Invested Capital (ROIC) of -27.04%. Per share, it reports EPS of $-5.55, diluted EPS of $-5.55, free cash flow per share of $-1.10, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -14.15% year-over-year, net income growth of 16.59% year-over-year, and EPS growth of 15.57% year-over-year. On the balance sheet, it maintains a current ratio of 1.82x, a quick ratio of 1.45x, working capital of $75.28M, a debt-to-equity ratio of 1.79x, a debt ratio of 0.64, an interest coverage ratio of -8.68x, free cash flow of $-7.08M (TTM), and net debt of $5.54M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-5.55
- ROE TTM
- -38.76%
- ROA TTM
- -14.34%
- Debt To Equity
- 1.79x
- Free Cash Flow TTM
- $-7.08M
- Net Revenue TTM Growth 1Y
- -14.15%
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Assertio Holdings, Inc. in?
Assertio Holdings, Inc. (ASRT) operates in the Pharmaceutical Preparations industry.
What exchange does ASRT trade on?
Assertio Holdings, Inc. (ASRT) trades on the Nasdaq.
Where is Assertio Holdings, Inc. incorporated?
Assertio Holdings, Inc. is incorporated in DE.
When was Assertio Holdings, Inc. (ASRT)'s most recent SEC filing?
Assertio Holdings, Inc. (ASRT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-08.
What is ASRT's EPS (earnings per share)?
Assertio Holdings, Inc. (ASRT)'s trailing twelve month EPS is $-5.55 as of 2026-03-31.
What is ASRT's ROE (return on equity)?
Assertio Holdings, Inc. (ASRT)'s trailing twelve month Return on Equity (ROE) is -38.76% as of 2026-03-31.
What is ASRT's ROA (return on assets)?
Assertio Holdings, Inc. (ASRT)'s trailing twelve month Return on Assets (ROA) is -14.34% as of 2026-03-31.
What is ASRT's ROIC (return on invested capital)?
Assertio Holdings, Inc. (ASRT)'s trailing twelve month Return on Invested Capital (ROIC) is -27.04% as of 2026-03-31.